These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3277317)

  • 21. Evidence that epichlorohydrin is not a toxic metabolite of 1,2-dibromo-3-chloropropane.
    Gingell R; Beatty PW; Mitschke HR; Mueller RL; Sawin VL; Page AC
    Xenobiotica; 1987 Feb; 17(2):229-40. PubMed ID: 3564537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro metabolism and bioactivation of 1,2,3-trichloropropane.
    Weber GL; Sipes IG
    Toxicol Appl Pharmacol; 1992 Mar; 113(1):152-8. PubMed ID: 1553750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutation spectrum of 1,2-dibromo-3-chloropropane, an endocrine disruptor, in the lacI transgenic Big Blue Rat2 fibroblast cell line.
    Ryu JC; Kim YJ; Chai YG
    Mutagenesis; 2002 Jul; 17(4):301-7. PubMed ID: 12110625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of oxidative and conjugative pathways in the activation of 1,2-dibromo-3-chloropropane to DNA-damaging products in rat testicular cells.
    Omichinski JG; Brunborg G; Holme JA; Søderlund EJ; Nelson SD; Dybing E
    Mol Pharmacol; 1988 Jul; 34(1):74-9. PubMed ID: 3393142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism of mutagenic amino-gamma-carbolines in tryptophan pyrolysates.
    Kato R; Yamazoe Y; Ishii K; Mita S; Kamataki T; Sugimura T
    Adv Exp Med Biol; 1981; 136 Pt B():997-1009. PubMed ID: 7046392
    [No Abstract]   [Full Text] [Related]  

  • 26. Interaction with microsomal lipid as a major factor responsible for S9-mediated inhibition of 1,8-dinitropyrene mutagenicity.
    Shah AB; Combes RD; Rowland IR
    Mutat Res; 1991 Jul; 249(1):93-104. PubMed ID: 2067546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The differential mutagenicity of isoniazid in fluctuation assays and Salmonella plate tests.
    Gatehouse D; Wedd DJ
    Carcinogenesis; 1984 Mar; 5(3):391-7. PubMed ID: 6368032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutagenicity of 2,6-dinitrotoluene and its metabolites, and their related compounds in Salmonella typhimurium.
    Sayama M; Mori M; Shirokawa T; Inoue M; Miyahara T; Kozuka H
    Mutat Res; 1989 Jul; 226(3):181-4. PubMed ID: 2664501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic activation of 3-nitroperylene in the Salmonella/S9 assay.
    Anderson JG; McCalla DR; Bryant DW; McCarry BE; Bromke AM
    Mutagenesis; 1987 Jul; 2(4):279-85. PubMed ID: 3325759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro effects of N-acetylcysteine on the mutagenicity of direct-acting compounds and procarcinogens.
    De Flora S; Bennicelli C; Zanacchi P; Camoirano A; Morelli A; De Flora A
    Carcinogenesis; 1984 Apr; 5(4):505-10. PubMed ID: 6368036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism and mutagenicity of N-nitrosohexamethyleneimine and its hydroxylated derivatives.
    Hecker LI; Saavedra JE; Andrews AW
    Teratog Carcinog Mutagen; 1983; 3(1):9-17. PubMed ID: 6132461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA damage and cell death induced by 1,2-dibromo-3-chloropropane (DBCP) and structural analogs in monolayer culture of rat hepatocytes: 3-aminobenzamide inhibits the toxicity of DBCP.
    Holme JA; Søderlund EJ; Brunborg G; Låg M; Nelson SD; Dybing E
    Cell Biol Toxicol; 1991 Oct; 7(4):413-32. PubMed ID: 1794113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microsomal metabolism of 1-nitrobenzo[e]pyrene to a highly mutagenic K-region dihydrodiol.
    Fu PP; Heflich RH; Von Tungeln LS; Miranda HZ; Evans FE
    Carcinogenesis; 1988 Jun; 9(6):951-8. PubMed ID: 3286032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extra-hepatic GSH-dependent metabolism of 1,2-dibromoethane (DBE) and 1,2-dibromo-3-chloropropane (DBCP) in the rat and mouse.
    MacFarland RT; Gandolfi AJ; Sipes IG
    Drug Chem Toxicol; 1984; 7(3):213-27. PubMed ID: 6376058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo effects of N-acetylcysteine on glutathione metabolism and on the biotransformation of carcinogenic and/or mutagenic compounds.
    De Flora S; Bennicelli C; Camoirano A; Serra D; Romano M; Rossi GA; Morelli A; De Flora A
    Carcinogenesis; 1985 Dec; 6(12):1735-45. PubMed ID: 3905042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutagenic activation of tris(2,3-dibromopropyl)phosphate: the role of microsomal oxidative metabolism.
    Søderlund EJ; Nelson SD; Dybing E
    Acta Pharmacol Toxicol (Copenh); 1979 Aug; 45(2):112-21. PubMed ID: 40390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alcoholdehydrogenase as an activating enzyme for N-nitrosodiethanolamine (NDELA): in vitro activation of NDELA to a potent mutagen in Salmonella typhimurium.
    Eisenbrand G; Denkel E; Pool B
    J Cancer Res Clin Oncol; 1984; 108(1):76-80. PubMed ID: 6378917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutagenicity of 1,2-dibromo-3-chloropropane (DBCP) in the mouse spot test.
    Sasaki YF; Imanishi H; Watanabe M; Sekiguchi A; Moriya M; Shirasu Y; Tutikawa K
    Mutat Res; 1986 Jun; 174(2):145-7. PubMed ID: 3713732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microsomal transformation of emodin into a direct mutagen.
    Masuda T; Ueno Y
    Mutat Res; 1984 Feb; 125(2):135-44. PubMed ID: 6366529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Critical evaluation of the cancer risk of dibromochloropropane (DBCP).
    Clark HA; Snedeker SM
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2005; 23(2):215-60. PubMed ID: 16291528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.